Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "keywords" (onkološko zdravljenje) .

51 - 60 / 152
First pagePrevious page234567891011Next pageLast page
51.
Radioterapija raka glave in vratu
Gaber Plavc, 2022, published professional conference contribution

Abstract: Radioterapija je eden treh stebrov zdravljenja rakov glave in vratu. Začetki segajo v konec 19. stoletja, vsa dosedanja spoznanja pa danes omogočajo uspešno zdravljenje ob sprejemljivi toksičnosti. S sodobnimi obsevalnimi tehnikami lahko pri sluzničnih karcinomih glave in vratu v zgodnjih stadijih dosežemo popolno lokalno kontrolo bolezni, medtem ko je pri lokoregionalni bolezni obsevanje pogosto edino zdravljenje, ki prinaša možnost ozdravitve. V prihodnosti lahko ob tehničnem napredku, kot sta uporaba adaptivnega pristopa k obsevanju in uporaba visokoenergijskih delcev z ugodnejšimi fizikalnimi lastnostmi, ter predvsem ob napredku v razumevanju mehanizmov občutljivosti na obsevanje pričakujemo nadaljnje pomembne korake k izboljšanju uspehov radioterapije ob nespremenjeni ali celo zmanjšani toksičnosti.
Keywords: rak glave in vratu, radioterapija, onkološko zdravljenje
Published in DiRROS: 06.01.2023; Views: 429; Downloads: 94
.pdf Full text (534,94 KB)

52.
Izbrane teme iz internistične onkologije za zdravnike družinske medicine, Ljubljana, junij 2022
2022, proceedings of peer-reviewed scientific conference contributions (domestic conferences)

Keywords: internistična onkologija, družinska medicina, onkološko zdravljenje
Published in DiRROS: 30.08.2022; Views: 555; Downloads: 340
.pdf Full text (56,64 MB)

53.
Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination
Urška Janžič, Urška Bidovec, Katja Mohorčič, Loredana Mrak, Nina Fokter Dovnik, Marija Ivanović, Maja Ravnik, Marina Čakš, Erik Škof, Jerneja Debeljak, Peter Korošec, Matija Rijavec, 2022, original scientific article

Abstract: Background: SARS-CoV-2 vaccination in cancer patients is crucial to prevent severe COVID-19 disease course. Methods: This study assessed immunogenicity of cancer patients on active treatment receiving mRNA-based SARS-CoV-2 vaccine by detection of anti-SARS-CoV-2 S1 IgG antibodies in serum, before, after the first and second doses and 3 months after a complete primary course of vaccination. Results were compared with healthy controls. Results: Of 112 patients, the seroconversion rate was 96%. A significant reduction in antibody levels was observed 3 months after vaccination in patients receiving immune checkpoint inhibitors versus control participants (p < 0.001). Adverse events were mostly mild. Conclusion: Immunogenicity after mRNA-based vaccine in cancer patients is adequate but influenced by the type of anticancer therapy. Antibody levels decline after 3 months, and thus a third vaccination is warranted.
Keywords: onkološko zdravljenje, imunogenost, osnovno cepljenje mRNA, čvrsti tumorji, anticancer treatment, immunogenicity, mRNA-based vaccination, solid cancer
Published in DiRROS: 24.06.2022; Views: 772; Downloads: 318
.pdf Full text (2,03 MB)

54.
55.
Imunoterapija pri ginekoloških rakih – zaviralci kritičnih točk
Tanja Mesti, 2021, published scientific conference contribution (invited lecture)

Keywords: ginekološki raki, rak jajčnikov, onkološko zdravljenje
Published in DiRROS: 31.03.2022; Views: 461; Downloads: 223
.pdf Full text (237,95 KB)
This document has many files! More...

56.
Stereotaktično obsevanje in imunoterapija pri raku jajčnikov
Barbara Šegedin, 2021, published scientific conference contribution (invited lecture)

Keywords: ginekološki raki, rak jajčnikov, onkološko zdravljenje
Published in DiRROS: 31.03.2022; Views: 413; Downloads: 237
.pdf Full text (271,03 KB)
This document has many files! More...

57.
Načrtovanje zdravljenja raka jajčnikov pri starejših in polimorbidnih bolnicah - razmislek o radikalnosti kirurgije
Špela Smrkolj, Vita Andreja Mesarič, 2021, published scientific conference contribution (invited lecture)

Keywords: ginekološki raki, rak jajčnikov, onkološko zdravljenje
Published in DiRROS: 30.03.2022; Views: 490; Downloads: 222
.pdf Full text (182,04 KB)
This document has many files! More...

58.
Bevacizumab pri zdravljenju raka jajčnikov
Nina Fokter Dovnik, 2021, published scientific conference contribution (invited lecture)

Keywords: ginekološki raki, rak jajčnikov, onkološko zdravljenje
Published in DiRROS: 30.03.2022; Views: 462; Downloads: 257
.pdf Full text (188,79 KB)
This document has many files! More...

59.
PARP inhibitrorji v prvi liniji zdravljenja raka jajčnika
Maja Ravnik, 2021, published scientific conference contribution (invited lecture)

Keywords: ginekološki raki, rak jajčnikov, onkološko zdravljenje
Published in DiRROS: 30.03.2022; Views: 443; Downloads: 246
.pdf Full text (247,85 KB)
This document has many files! More...

60.
Napovedni model uspešnosti primarne citoredukcije pri zdravljenju raka jajčnikov
Sebastjan Merlo, 2021, published scientific conference contribution (invited lecture)

Keywords: ginekološki raki, rak jajčnikov, onkološko zdravljenje
Published in DiRROS: 30.03.2022; Views: 473; Downloads: 218
.pdf Full text (178,95 KB)
This document has many files! More...

Search done in 0.29 sec.
Back to top